Treatment of myelodysplastic syndrome, acute leukemia and chronic myelomonocytic leukemia with 5-azacytidine: Comparative results from a single centre

被引：0
|
作者：
Montalvao, A. [1 ]
机构：
[1] Unidade Local Saude Baixo Alentejo, Hematol, Beja, Portugal
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70352-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-305
引用
收藏
页码：S159 / S160
页数：2
相关论文
共 50 条
  • [41] 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis
    Czibere, A.
    Bruns, I.
    Kroeger, N.
    Platzbecker, U.
    Lind, J.
    Zohren, F.
    Fenk, R.
    Germing, U.
    Schroeder, T.
    Graef, T.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 (05) : 872 - 876
  • [42] On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
    Feldman, E. J.
    Cortes, J.
    DeAngelo, D. J.
    Holyoake, T.
    Simonsson, B.
    O'Brien, S. G.
    Reiffers, J.
    Turner, A. R.
    Roboz, G. J.
    Lipton, J. H.
    Maloisel, F.
    Colombat, P.
    Martinelli, G.
    Nielsen, J. L.
    Petersdorf, S.
    Guilhot, F.
    Barker, J.
    Kirschmeier, P.
    Frank, E.
    Statkevich, P.
    Zhu, Y.
    Loechner, S.
    List, A.
    LEUKEMIA, 2008, 22 (09) : 1707 - 1711
  • [43] On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
    E J Feldman
    J Cortes
    D J DeAngelo
    T Holyoake
    B Simonsson
    S G O'Brien
    J Reiffers
    A R Turner
    G J Roboz
    J H Lipton
    F Maloisel
    P Colombat
    G Martinelli
    J L Nielsen
    S Petersdorf
    F Guilhot
    J Barker
    P Kirschmeier
    E Frank
    P Statkevich
    Y Zhu
    S Loechner
    A List
    Leukemia, 2008, 22 : 1707 - 1711
  • [44] 5-Azacytidine Reduces Leukemic Burden in a Xenograft Model of Juvenile Myelomonocytic Leukemia
    Krombholz, Christopher Felix
    Meier, Angelina
    Aumann, Konrad
    Fluhr, Silvia
    Kollek, Matthias
    Lipka, Daniel B.
    Plass, Christoph
    Witte, Tania
    Niemeyer, Charlotte
    Erlacher, Miriam
    Flotho, Christian
    BLOOD, 2015, 126 (23)
  • [45] CHRONIC MYELOMONOCYTIC LEUKEMIA (CMMOL) PLUS THE MYELODYSPLASTIC SYNDROME
    WICKRAMANAYAKE, PD
    PALLENSCHAT, J
    DIEHL, V
    MEDIZINISCHE KLINIK, 1991, 86 (08) : 383 - 386
  • [46] CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) - A MYELODYSPLASTIC OR MYELOPROLIFERATIVE SYNDROME
    MICHAUX, JL
    MARTIAT, P
    LEUKEMIA & LYMPHOMA, 1993, 9 (1-2) : 35 - 41
  • [47] Successful 5-azacytidine treatment of myeloid sarcoma and leukemia cutis associated with myelodysplastic syndrome A case report and literature review
    Katagiri, Takayuki
    Ushiki, Takashi
    Masuko, Masayoshi
    Tanaka, Tomoyuki
    Miyakoshi, Shukuko
    Fuse, Kyoko
    Shibasaki, Yasuhiko
    Takizawa, Jun
    Aoki, Sadao
    Sone, Hirohito
    MEDICINE, 2017, 96 (36)
  • [48] CONTINUOUS INFUSION OF 5-AZACYTIDINE AS INDUCTION FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN PATIENTS WITH PREVIOUS EXPOSURE TO 5-AZACYTIDINE
    GAYNON, PS
    BAUM, ES
    ONCOLOGY, 1983, 40 (03) : 192 - 194
  • [49] 5-Azacitidine Therapy in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia: a Single Institution Experience
    Freyrie, Alessandra
    Reda, Gianluigi
    Vincenti, Daniele
    Sciume, Mariarita
    Binda, Francesca
    Guidotti, Francesca
    Cortelezzi, Agostino
    BLOOD, 2012, 120 (21)
  • [50] EFFECT OF SCHEDULE ON ACTIVITY OF 5-AZACYTIDINE IN ACUTE-LEUKEMIA
    SAIKI, J
    HEWLETT, J
    BODEY, G
    AMARE, M
    MORRISON, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 441 - 441
12345